Cargando…
Ethylmalonic encephalopathy: Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation
Ethylmalonic encephalopathy (EE) is a rare metabolic disorder caused by dysfunction of ETHE1 protein, a mitochondrial dioxygenase involved in hydrogen sulfide (H(2)S) detoxification. EE is usually a fatal disease with a severe clinical course mainly associated with developmental delay and regression...
Autores principales: | Ersoy, Melike, Tiranti, Valeria, Zeviani, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476058/ https://www.ncbi.nlm.nih.gov/pubmed/32923369 http://dx.doi.org/10.1016/j.ymgmr.2020.100641 |
Ejemplares similares
-
Ethylmalonic Encephalopathy ETHE1 R163W/R163Q Mutations Alter Protein Stability and Redox Properties of the Iron Centre
por: Henriques, Bárbara J., et al.
Publicado: (2014) -
Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy
por: Di Meo, Ivano, et al.
Publicado: (2012) -
Ethylmalonic encephalopathy masquerading as meningococcemia
por: Horton, Ari, et al.
Publicado: (2022) -
Neurological and Vascular Manifestations of Ethylmalonic Encephalopathy
por: TAVASOLI, Ali Reza, et al.
Publicado: (2017) -
Novel Compound Heterozygous Variants of ETHE1 Causing Ethylmalonic Encephalopathy in a Chinese Patient: A Case Report
por: Chen, Xiaohong, et al.
Publicado: (2020)